Veloxis_logo - Color - Screen.png
Veloxis to Host Conference Call Following Release of Interim Financial Report for the Period 1 January to 30 June 2019
August 06, 2019 01:07 ET | Veloxis Pharmaceuticals A/S
Investor News no. 04/2019 To: NASDAQ Copenhagen A/S                                                   Copenhagen, Denmark, 6 August 2019 Veloxis to Host Conference Call Following Release of...
Veloxis_logo - Color - Screen.png
Veloxis Revises Outlook for 2019 Based on Strong Performance
July 22, 2019 11:46 ET | Veloxis Pharmaceuticals A/S
Company Release no. 11/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 22 July 2019 Veloxis Revises Outlook for 2019 Based on Strong...
Veloxis_logo - Color - Screen.png
Veloxis Increases Share Capital in Connection with Exercise of Warrants
June 03, 2019 17:37 ET | Veloxis Pharmaceuticals A/S
Company Release no. 10/2019 To: NASDAQ Copenhagen A/S                                                       Copenhagen, Denmark, 03 June 2019   Veloxis Increases Share Capital in Connection...
Veloxis_logo - Color - Screen.png
Envarsus XR® to be Subject of Upcoming Presentations at 2019 American Transplant Congress
May 31, 2019 17:08 ET | Veloxis Pharmaceuticals A/S
Investor News no. 03/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 31 May 2019 Envarsus XR® to be Subject of Upcoming Presentations...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
May 07, 2019 17:17 ET | Veloxis Pharmaceuticals A/S
Company Release no. 09/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 07 May 2019   Veloxis Pharmaceuticals A/S Grants Warrants Under...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2019
May 06, 2019 11:25 ET | Veloxis Pharmaceuticals A/S
Company Release no. 08/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 06 May 2019   Veloxis Pharmaceuticals Announces Financial Results for...
Veloxis_logo - Color - Screen.png
Veloxis to Host Conference Call Following Release of Interim Financial Report for the Period 1 January to 31 March 2019
May 01, 2019 16:15 ET | Veloxis Pharmaceuticals A/S
Investor News no. 02/2019 To: NASDAQ Copenhagen A/S                                                   Copenhagen, Denmark, 1 May 2019   Veloxis to Host Conference Call Following Release of...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
April 04, 2019 17:19 ET | Veloxis Pharmaceuticals A/S
Company Release no. 07/2019 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 04 April 2019 Veloxis Pharmaceuticals A/S Grants...
Veloxis_logo - Color - Screen.png
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019
April 03, 2019 03:54 ET | Veloxis Pharmaceuticals A/S
Company Release no. 06/2019 To: NASDAQ Copenhagen A/S                                                       Copenhagen, Denmark, 03 April 2019   Veloxis Pharmaceuticals A/S - Passing of Annual...
Veloxis_logo - Color - Screen.png
Veloxis Increases Share Capital in Connection with Exercise of Warrants
April 02, 2019 17:33 ET | Veloxis Pharmaceuticals A/S
Company Release no. 05/2019 To: NASDAQ Copenhagen A/S                                                       Copenhagen, Denmark, 02 April 2019   Veloxis Increases Share Capital in Connection...